Patents by Inventor Karen E. Morrison

Karen E. Morrison has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Alpha-3 chain type IV collagen polypeptides
    Patent number: 6007980
    Abstract: An isolated and substantially pure polynucleotide encoding 238 amino acids of the carboxy terminal end of the triple helical domain and all 233 amino acids of the carboxy terminal noncollageneous domain of the bovine .alpha.3 chain of type IV collagen. An isolated and substantially pure polynucleotide encoding 218 amino acids of the carboxy terminal noncollagenous domain of the human .alpha.3 chain of type IV collagen. Such polynucleotides are useful to express large amounts of proteins in vectors and such expressed proteins are useful to detect Goodpasture antibodies in blood and to remove Goodpasture antibodies from the bloodstream of patients suffering from Goodpasture syndrome.
    Type: Grant
    Filed: October 7, 1998
    Date of Patent: December 28, 1999
    Assignees: Yale University, University of Kansas Medical Center
    Inventors: Stephen T. Reeders, Karen E. Morrison, Billy G. Hudson
  • .alpha.-3 chain type IV collagen polypeptides
    Patent number: 5973120
    Abstract: An isolated and substantially pure polynucleotide encoding 238 amino acids of the carboxy terminal end of the triple helical domain and all 233 amino acids of the carboxy terminal noncollageneous domain of the bovine .alpha.3 chain of type IV collagen. An isolated and substantially pure polynucleotide encoding 218 amino acids of the carboxy terminal noncollagenous domain of the human .alpha.3 chain of type IV collagen. Such polynucleotides are useful to express large amounts of proteins in vectors and such expressed proteins are useful to detect Goodpasture antibodies in blood and to remove Goodpasture antibodies from the bloodstream of patients suffering from Goodpasture syndrome.
    Type: Grant
    Filed: March 7, 1995
    Date of Patent: October 26, 1999
    Assignees: Yale University, University of Kansas Medical Center
    Inventors: Stephen T. Reeders, Karen E. Morrison, Billy G. Hudson
  • .alpha.-3 chain type IV collagen polynucleotides
    Patent number: 5424408
    Abstract: An isolated and substantially pure polynucleotide encoding 238 amino acids of the carboxy terminal end of the triple helical domain and all 233 amino acids of the carboxy terminal noncollageneous domain of the bovine .alpha.3 chain of type IV collagen. An isolated and substantially pure polynucleotide encoding 218 amino acids of the carboxy terminal noncollagenous domain of the human .alpha.3 chain of type IV collagen. Such polynucleotides are useful to express large amounts of proteins in vectors and such expressed proteins are useful to detect Goodpasture antibodies in blood and to remove Goodpasture antibodies from the bloodstream of patients suffering from Goodpasture syndrome.
    Type: Grant
    Filed: November 30, 1990
    Date of Patent: June 13, 1995
    Assignees: Yale University, The University of Kansas Medical Center
    Inventors: Stephen T. Reeders, Karen E. Morrison, Billy G. Hudson